Forecasting drugs that don't exist yet.
Bottom-up market sizing and subnational access for first-in-class UK pharma launches.
About
Chris Barton.
Pharmaceutical commercial director and market access specialist. Director & owner of Nexus Pharma Consulting; General Manager at nzyme, unpicking subnational access blocks for UK launches. Passionate about building empowered, high-performing teams.
BSc Physiology & Pharmacology, University of Southampton. Based in Grayshott, England.
"Bottom-up, transparent, stress-tested — the forecast any auditor can follow."
The method
"Twenty years of launches, portfolios, and subnational access — distilled into what actually moves the number."
Track record